We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UBSG:SIXUBS Group AG Analysis

Data as of 2026-09-05 - not real-time

CHF 44.81

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

UBS Group AG is priced at CHF 44.81 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 5.9%. RSI sits at 66.2, which reads as approaching overbought, and MACD momentum is bullish. Watch CHF 42.15 as support and CHF 44.95 as the nearer resistance level.
The shares look fair, trading on 18.7 times earnings above a sector average of 16.5. Revenue is growing at 14.6% on a 17.9% profit margin. The 1.94% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 13.3%, a beta of 0.28 and a maximum drawdown of 23.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.

Top Market Events

UBS Group stock has delivered a very strong 225.UBS Group stock reflects the bank's 2025 earnings, dividend and capital position as investors weighUBS Group AG UBS reports a robust $2.8 billion net profit and unveils a $3 billion share repurchase program amid strong...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 36.48
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 18.7 versus sector average of 16.5
  • Trading above the 200-day average of 36.48

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 18.7 versus sector average of 16.5
  • Profit margin of 17.9% is healthy
  • Revenue growth of +14.6%

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin17.95%
P/E Ratio18.7
ROE10.67%
ROA0.57%
P/B Ratio1.9
Op. Cash FlowCHF14.2B
Industry P/E16.5

Technical Analysis

TrendBullish
RSI66.2
SupportCHF 42.15
ResistanceCHF 44.95
MA 20CHF 43.70
MA 50CHF 42.85
MA 200CHF 36.48
MACDBullish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair ValueCHF 67.35
Target PriceCHF 44.16
Upside/Downside-1.44%
GradeFair
TypeBlend
Dividend Yield1.94%

Risk Assessment

Beta0.28
Volatility13.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.